World Journal of Gastroenterology

Papers
(The H4-Index of World Journal of Gastroenterology is 51. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Carcinoid syndrome caused by a pulmonary carcinoid mimics intestinal manifestations of ulcerative colitis: A case report346
Comment on “Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer”337
Very early onset perinatal constipation: Can it be cow’s milk protein allergy?337
Molecular mechanisms implicated in SARS-CoV-2 liver tropism236
Return to work in young and middle-aged colorectal cancer survivors: Factors influencing self-efficacy, fear, resilience, and financial toxicity224
Endoscopic intramural cystogastrostomy for treatment of peripancreatic fluid collection: A viewpoint from a surgeon176
Knowledge and attitudes towards the use of histological assessments in ulcerative colitis by gastroenterologists vs pathologists150
Unresolved conundrum of the role of physical activity in irritable bowel disease: What next?145
Link between pharyngeal acid reflux episodes and the effectiveness of proton pump inhibitor therapy133
Improving early diagnosis of multiple endocrine neoplasia type 1 by assessing the gastrointestinal symptoms, hypercalcemia, and elevated serum gastrin123
Three-dimensional location approach with silk thread guided hepatectomy for liver tumor116
Parasites of the liver: A global problem?106
Beyond biomarkers: An integrated traditional Chinese medicine-machine learning approach predicts hepatic steatosis in high metabolic risk populations106
Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment104
Contributions of the receptor for advanced glycation end products axis activation in gastric cancer103
Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The “BE-FIT-IBD” study103
Liver parasites: A global endemic and journey from infestation to intervention97
Prostaglandin F2α synthase promotes oxaliplatin resistance in colorectal cancer through prostaglandin F2α-dependent and F2α-independent mechanism94
Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease94
Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication92
Gastroenterology in the age of artificial intelligence: Bridging technology and clinical practice75
Machine learning algorithms reveal gut microbiota signatures associated with chronic hepatitis B-related hepatic fibrosis75
Divergent trajectories of lean vs obese non-alcoholic steatohepatitis patients from listing to post-transplant: A retrospective cohort study75
Validation of prognostic scores for predicting acute liver failure and in-hospital death in patients with dengue-induced severe hepatitis70
Gastroesophageal reflux after per-oral endoscopic myotomy: Management literature67
Influence of blood transfusion on postoperative inflammation, stress markers, and prognosis in patients with gastric cancer66
Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity66
Colorectal motility patterns and psychiatric traits in functional constipation and constipation-predominant irritable bowel syndrome: A study from China64
Artificial intelligence system for the detection of Barrett’s esophagus63
New objective scoring system to clinically assess fecal incontinence62
Perianal fistulizing Crohn’s disease: Mechanisms and treatment options focusing on cellular therapy61
Amoxicillin high-dose dual therapy for Helicobacter pylori primary eradication: Proton pump inhibitor and potassium-competitive acid blocker, which’s better?61
Gastric pentadecapeptide BPC 157 in cytoprotection to resolve major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome61
Systemic treatment for metastatic colorectal cancer61
Bridging the gap: Unveiling the crisis of physical inactivity in inflammatory bowel diseases60
Prognostic impact and reasons for variability by tumor location in gastric cancer59
Nonlinear association between estimated plasma volume status and acute kidney injury in acute pancreatitis patients59
Suberoylanilide hydroxamic acid upregulates reticulophagy receptor expression and promotes cell death in hepatocellular carcinoma cells58
Fibroblast growth factor 15, induced by elevated bile acids, mediates the improvement of hepatic glucose metabolism after sleeve gastrectomy58
Relationship between clinical remission of perianal fistulas in Crohn’s disease and serum adalimumab concentrations: A multi-center cross-sectional study57
Gastroesophageal reflux following peroral endoscopic myotomy for achalasia: Bumps in the road to success56
Back to the drawing board: Overview of the next generation of combination therapy for inflammatory bowel disease56
GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis55
Ethnic genomic differences in esophageal squamous cell carcinoma: Whole-exome sequencing of Han and Kazakh populations in China54
Role of one-step nucleic acid amplification in colorectal cancer lymph node metastases detection54
Endo-hepatology: Bridging the gap between lumen and liver54
Factors other than fibrosis that increase measured shear wave velocity53
Modern drug discovery for inflammatory bowel disease: The role of computational methods52
Involvement of nitrergic neurons in colonic motility in a rat model of ulcerative colitis51
Machine learning identifies the risk of complications after laparoscopic radical gastrectomy for gastric cancer51
Examining dietary interventions in Crohn’s disease51
Intestinal flora was associated with occurrence risk of chronic non-communicable diseases51
0.30002808570862